Cryoport, a provider of temperature-controlled supply chain services, has purchased Cell & Co. BioServices.
Cell & Co. is a trusted partner of manufacturers and laboratories involved in the life sciences markets. The firm is a bioservices business providing biorepository, kitting, and logistics services to the life sciences industry. Cryoport provides supply chain services for the life sciences industry supporting life-saving cell and gene therapies across the clinical and commercial spectrum.
“The cell and gene therapy market is expected to grow rapidly and is a significant focus for us. We are proud of the work we have accomplished and even more of joining the Cryoport group with its objective of making medical innovation achievable and more reliable for the benefit of patients around the world,” said Sofien Dessolin and Florent Belon, founders of Cell & Co. BioServices. “We are excited to be part of Cryoport’s strategic platform in the advanced therapies space in EMEA and look forward to continuing to lead Cell & Co. as an integral part of Cryoport as it builds out its Global Supply Chain Network and other services.”